Delivery Order SPE2DB25D3020-SPE2DB25FWJRU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,760.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60gm), a topical pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,875.38 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $9,046.93 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price contract represents a non-competitive set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,274.94 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in a 60-gram formulation on December 18, 2025, with an ultimate completion date of December 19, 2025. This non-competitive, firm fixed-price delivery order represents a small-value pharmaceutical procurement fulfilling immediate medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed...
- The Defense Logistics Agency awarded a delivery order valued at $6,287.04 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream 60GM, a topical pharmaceutical product. This firm fixed price delivery order, awarded on November 28, 2025, with an ultimate completion date of December 1, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,620.90 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on August 12, 2025, with completion expected by August 13, 2025. This is a firm fixed-price, non-competitive delivery order under the company's existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,014.35 to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of OPZELURA 1.5% Cream in 60-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 30, 2025. The contract represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement, with performance taking...
- The Defense Logistics Agency awarded a $16,474.15 delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram units under a firm fixed-price contract. This non-set-aside delivery order was competitively awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,855.66 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram units under a firm fixed-price contract type. This award, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing...
- The Defense Logistics Agency awarded a delivery order valued at $2,909.76 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM), a topical pharmaceutical product. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on July 18, 2025, with an ultimate completion date of July 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWJRUDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,174.81 for OPZELURA 1.5% Cream (60gm), a topical pharmaceutical product. This firm fixed-price contract, awarded on July 24, 2025, with completion scheduled for July 25, 2025, carries no set-aside designation and represents a competitively awarded procurement. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a primary pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other government agencies. The parent IDC serves as a global pharmaceutical support vehicle enabling flexible fulfillment of medical commodity needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 7/24/25 |